The liver in AIDS

Seminars in Liver Disease

Volumn 17, Issue 4, 1997, Pages 335-344

  Lefkowitch, Jay H ^a  

^a Columbia University ^*  (United States)

Author keywords

Acquired immune deficiency syndrome; AIDS; Liver biopsy; Liver pathology; Viral hepatitis

Indexed keywords

DIDANOSINE; SULFANILAMIDE DERIVATIVE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL INFECTION; BILIARY TRACT DISEASE; CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KUPFFER CELL; LIVER ABSCESS; LIVER DISEASE; LIVER GRANULOMA; LIVER TOXICITY; LIVER TUMOR; MYCOSIS; NONHUMAN; PELIOSIS HEPATIS; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVIEW; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS HEPATITIS;

EID: 0030695333     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007210     Document Type: Review

References (98)

1. Lefkowitch JH. Pathology of AIDS-related liver disease. Dig Dis 12:321-330, 1994.
2. Lebovics E, Thung SN, Schaffner F, et al. The liver in the acquired immunodeficiency syndrome: A clinical and histologic study. Hepatology 5:293-298, 1985.
3. Glasgow BJ, Anders K, Layfield LJ, et al. Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS). Am J Clin Pathol 83:582-588, 1985.
4. Dworkin BM, Stahl RE, Giardina MA, et al. The liver in acquired immune deficiency syndrome: Emphasis on patients with intravenous drug abuse. Am J Gastroenterol 82:231-236, 1987.
5. Schneiderman DJ, Arenson DM, Cello JP, et al. Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS). Hepatology 7:925-930, 1987.
6. Lebovics E, Dworkin BM, Heier SK, et al. The hepatobiliary manifestations of human immunodeficiency virus infection. Am J Gastroenterol 83:1-7, 1988.
7. Wilkins MJ, Lindley R, Dourakis SP, et al. Surgical pathology of the liver in HIV infection. Histopathology 18:459-464, 1991.
8. Comer GM. Hepatobiliary disease in AIDS, in Kotler DP (ed): Gastrointestinal and nutritional Manifestations of AIDS. New York, Raven Press, 1991, pp 119-140.
9. Bach N, Theise ND, Schaffner F. Hepatic histopathology in the acquired immunodeficiency syndrome. Semin Liver Dis 12: 205-212, 1992.
10. Cappell MS. Hepatobiliary manifestations of the acquired immune deficiency syndrome. Am J Gastroenterol 86:1-15, 1991
11. Scoazec JY, Feldmann G. Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus Hepatology 12:505-510, 1990.
12. Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection: Review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis 168:1490-1501, 1993.
13. Witzleben CL, Marshall GS, Wenner W, et al. HIV as a cause of giant cell hepatitis. Hum Pathol 19:603-605, 1988.
14. Molina J-M, Welker Y, Ferchal F, et al. Hepatitis associated with primary HIV infection. Gastroenterology 102:739-746, 1992.
15. Forsmark CE. AIDS and the gastrointestinal tract. Postgrad Med 93:143-152, 1993.
16. Housset C, Lamas E, Courgnaud V, et al. Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo. J Hepatol 19:252-258, 1993.
17. Hufert FT, Schmitz J, Schreiber M, et al. Human Kupffer cells infected with HIV-1 in vivo. J AIDS 6:772-777, 1993.
18. Persidsky Y, Steffan A-M, Gendrault J-L, et al. Permissiveness of Kupffer cells for simian immunodeficiency virus (SIV) and morphological changes in the liver of rhesus monkeys at different periods of SIV infection. Hepatology 21:1215-1225, 1995.
19. Gerber MA, Chen M-L, Hu F-S, et al. Liver disease in rhesus monkeys infected with simian immunodeficiency virus Am J Pathol 139:1081-1088, 1991.
20. Steffan A-M, Lafon M-E, Gendrault J-L, et al. Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proc Natl Acad Sci USA 89:1582-1586, 1992.
21. Lafon M-E, Kirn A. Human immunodeficiency virus infection of the liver. Semin Liver Dis 12:197-204, 1992.
22. Sieratzki J, Thung SN, Gerber MA, et al. MHC antigens expression in the liver in AIDS. Arch Pathol Lab Med 111: 1045-1049, 1987.
23. Guido M, Rugge M, Rocchetto P, et al. HLA-DR expression in liver in human HIV infection. Liver 15:126-130, 1995.
24. Weiss, RA. HIV receptors and the pathogenesis of AIDS Science 272. 1885-1886, 1996.
25. Beaugerie L, Teilhac M-F, Deluol A-M, et al. Cholangiopathy associated with microsporidia infection of the common bile duct mucosa in a patient with HIV infection. Ann Intern Med 117:401-402, 1992.
26. Pol S, Romana C, Richard S, et al. Enterocytozoon bieneusi infection in acquired-immunodeficiency syndrome-related sclerosing cholangitis. Gastroenterology 102:1778-1781, 1992.
27. Pol S, Romana CA, Richard S, et al. Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med 328:95-99, 1993.
28. Margulis SJ, Honig CL, Soave R, et al. Biliary tract obstruction in the acquired immunodeficiency syndrome [published erraturn appears in Ann Intern Med 1986 Oct; 105(4):634]. Ann Intern Med 105.207-210, 1986.
29. Cello J. Human immunodeficiency virus-associated biliary tract disease. Semin Liver Dis 12 213-218, 1992.
30. Bouche H, Housset C, Dumont J-L, et al. AIDS-related cholangitis: Diagnostic features and course in 15 patients. J Hepatol 17:34-39, 1993
31. Case records of the Massachusetts General Hospital, Case 3-1995. N Engl J Med 332:249-257, 1995.
32. Sievert W, La Brooy JT, HIV-related gastrointestinal disease. Med J Aust 158.175-178, 1993.
33. Sehonanda A, Choi YJ, Blum S. Changing patterns of autopsy findings among persons with acquired immunodeficiency syndrome in an inner-city population. A 12-year retrospective study. Arch Pathol Lab Med 120:459-464, 1996.
34. Cavicchi M, Pialoux G, Carnot F, et al. Value of liver biopsy for the rapid diagnosis of infection in human immunodeficiency virus-infected patients who have unexplained fever and elevated serum levels of alkaline phosphatase or gamma-glutamyl transferase. Clin Infect Dis 20:606-610, 1995.
35. Cappell MS, Schwartz MS, Biempica L. Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus. Am J Med 88:123-130, 1990.
36. Lucas SB. Other viral and infectious diseases and HIV-related liver disease, in MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC (eds): Pathology of the Liver. Edinburgh, Churchill Livingstone, 1994, pp 269-315.
37. Bonacini M, Kanel G, Alamy M. Duodenal and hepatic toxoplasmosis in a patient with HIV infection: Review of the literature. Am J Gastroenterol 91:1838-1840, 1996.
38. Gordin FM, Simon GL, Wofsky CB, et al Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 100:495-499, 1984.
39. Willson R, Harrington R, Stewart B, et al. T. Human immunodeficiency virus 1-associated necrotizing cholangitis caused by infection with Septata intestinalis. Gastroenterology 108:247-251, 1995.
40. Forbes A, Blanchard C, Gazzard BG. Natural history of AIDS sclerosing cholangitis: A study of 20 cases. Gut 34:116-121, 1993.
41. McGowan I, Hawkins AS, Weller IVD. The natural history of cryptospondial diarrhoea in HIV-infected patients. AIDS 7:349-354, 1993.
42. Teare JP, Price DA, Foster GR, et al. Reversible AIDS-related sclerosing cholangitis. J Hepatol 23:209-211, 1995.
43. Kaplan LD, Kahn J, Jacobson M, et al. Primary bile duct lymphoma in the acquired immunodeficiency syndrome. Ann Intern Med 110:161-162, 1989
44. Knowles DM, Chamulak GA, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:744-753, 1988.
45. Ioachim HL, Cooper MC, Hellman GC. Hodgkin's disease and the acquired immunodeficiency syndrome. [Letter]. Ann Intern Med 101:876-877, 1984.
46. Scheib RG, Siegel RS. Atypical Hodgkin's disease and the acquired immunodeficiency syndrome [Letter]. Ann Intern Med 102.554, 1985.
47. Ross JS, Del Rosario A, Bui HX, et al. Primary hepatic leiomyosarcoma in a child with the acquired immunodeficiency syndrome. Hum Pathol 23 69-72, 1992.
48. van Hoeven KH, Factor SM, Kress Y, et al. Visceral myogenic tumors. A manifestation of HIV infection in children. Am J Surg Pathol 17:1176-1181, 1993.
49. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 332:12-18, 1995.
50. Hasan FA, Jeffers LJ, Welsh SW, et al. Hepatic involvement as the primary manifestation of Kaposi's sarcoma in the acquired immune deficiency syndrome. Am J Gastroenterol 84:1449-1451, 1989.
51. Caccamo D, Pervez NK, Marchevsky A. Primary lymphoma of the liver in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 110:553-555, 1986.
52. Welch K, Finkbeiner W, Alpers CE, et al. Autopsy findings in the acquired immunodeficiency syndrome. JAMA 252:1152-1159, 1984.
53. Prévot S, Néris J, de Saint Maur PP. Detection of Epstein Barr virus in a hepatic leiomyomatous neoplasm in an adult human immunodeficiency virus 1-infected patient. Virchows Arch 425:321-325, 1994.
54. Newell A, Francis N, Nelson M. Hepatitis and HIV: Interrelationship and interactions. Br J Clin Pract 49:247-251, 1995.
55. Horvath J, Raffanti SP. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clin Infect Dis 18:339-347, 1994.
56. Mai AL, Yim C, O'Rourke K, et al. The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men. J Clin Gastroenterol 22:299-304, 1996.
57. Vento S, di Peri G, Luzzati R, et al. Clinical reactivation of hepatitis B in anti-HBs positive patients with AIDS. Lancet 1:332-333, 1989.
58. Gilson RJC, Tedder RS, Weller IVD. Hepatitis B: Reactivation or reinfection associated with HIV-1 infection. Lancet 1:1330, 1989.
59. Waite J, Gilson JC, Weller IVD, et al. Hepatitis B virus reactivation of reinfection associated with HIV-1 infection. AIDS 2: 443-448, 1988.
60. Bonacini M, Govindarajan S, Russell J, et al. Intrahepatic viral load in patients with hepatitis C, with and without HIV infection. Hepatology 24:388A, 1996.
61. Areias J, Pedroto I, Freitas T, et al. Chronic hepatitis C virus infection in HIV-positive patients: Role of host immunity. Hepatology 24:478A, 1996.
62. Seto Y, Ueda M, Higasa S, et al. Effect of coinfection with human immunodeficiency virus on hepatitis C virus infected hemophiliacs. Hepatology 24:577A, 1996.
63. DiMartino V, Rufat P, Martine M, et al. Influence of HIV infection on the outcome of chronic hepatitis C. Hepatology 24: 382A, 1996.
64. Abe K, Ishikawa K, Nakai K, et al. High prevalence of HGV infection among Ghanian patients infected with HIV. Hepatology 24:475A, 1996.
65. Masih AS, Linder J, Shaw BW, et al. Rapid identification of cytomegalovirus in liver allograft biopsies by in situ hybridization Am J Surg Pathol 12:362-367, 1988
66. Naoumov NV, Alexander GJM, O'Grady JG, et al. Rapid diagnosis of cytomegalovirus infection by in-situ hybridisation in liver grafts. Lancet 1:1361-1364, 1988.
67. Theise ND, Conn M, Thung SN. Localization of cytomegalovirus antigens in liver allografts over time. Hum Pathol 24: 103-108, 1993.
68. Adal KA, Cockerell CJ, Petri WA Jr Cat scratch disease, bacillary angiomatosis, and other infections due to Rochalimaea. N Engl J Med 330:1509-1515, 1994.
69. Czapar CA, Weldon-Linne CM, Moore DM, et al. Peliosis hepatis in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 110:611-613, 1986.
70. Gordon SC, Reddy KR, Gould EE, et al. The spectrum of liver disease in the acquired immunodeficiency syndrome. J Hepatol 2.475-484, 1986.
71. Boylston AW, Cook HT, Francis ND, et al. Biopsy pathology of acquired immune deficiency syndrome (AIDS). J Clin Pathol 40:1-8, 1987.
72. Dubin G, Braffman MN. Zidovudine-induced hepatotoxicity. Ann Intern Med 110:85-86, 1989.
73. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 317:192-197, 1987.
74. Bissuel F, Bruneel F, Habersetzer F, et al. Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J Intern Med 235:367-372, 1994.
75. Olano JP, Borucki MJ, Wen JW, et al. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin Infect Dis 21:973-976, 1995.
76. Freiman JP, Helfert KE, Hamrell MR, et al. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 7:379-385, 1993.
77. Fernandez-Miranda C, Colina F, Delgado JM, et al. Diffuse nodular regenerative hyperplasia of the liver associated with human immunodeficiency virus and visceral leishmaniasis. Am J Gastroenterol 88:433-435, 1993.
78. Kossaifi T, Dupon M, Le Bail B, et al. Perisinusoidal cell hypertrophy in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 114-876-879, 1990.
79. Osick LA, Lee T-P, Pedemonte MB, et al. Hepatic amyloidosis in intravenous drug abusers and AIDS patients. J Hepatol 19: 79-84, 1993
80. Grunfeld C, Kotler DP. Wasting in the acquired immunodeficiency syndrome. Semin Liver Dis 12:175-187, 1992.
81. Bodsworth N, Cooper D, Donovan B. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis 163:1138-1140, 1991.
82. Collier A, Corey L, Murphy V, et al. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 109:101-105, 1988.
83. Tayal SC, Sanker KN. Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV infected individuals. AIDS 8:558-559, 1994
84. Bonacini M, Govindarajan S, Redeker AG. Human immunodeficiency virus infection does not alter serum transaminases and hepatitis B virus (HBV) DNA in homosexual patients with chronic HBV infection. Am J Gastroenterol 86:570-573, 1991.
85. Krogsgaard K, Lindhardt B, Nielson J, et al. The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology 7:37-41, 1987.
86. Trent Mills C, Lee E, Perrillo R. Relationship between histology, aminotransferase levels and viral replication in chronic hepatitis B. Gastroenterology 99:519-524, 1990.
87. Goldin RD, Fish DE, Hay A, et al. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection. J Clin Pathol 43.203-205, 1990.
88. Perrillo R, Regenstein FG, Roodman S. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Ann Intern Med 105:382-383, 1986.
89. Housset C, Pol S, Carnot F, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology 15:578-583, 1992.
90. Chen DK, Yim C, Krajden M, et al. Long term follow-up of a randomized controlled trial of interferon therapy for chronic hepatitis B in a predominantly male homosexual population. Hepatology 24-280A, 1996.
91. Gilson RJC, Hawkins AE, Kelly GK, et al. No effect of zidovudine on hepatitis B virus replication in homosexual men with symptomatic HIV-1 infection. AIDS 5:217-220, 1991.
92. Fried MW, Korenman JC, Di Bisceglie AM, et al. A pilot study of 2',3'-dideoxyinosine for the treatment of chronic hepatitis B Hepatology 16:861-864, 1992.
93. Eyster EM, Diamondstone LS, Lien JM, et al. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of co-infection with human immunodeficiency virus. J AIDS 6:602-610, 1993.
94. Wright TL, Hollander H, Pu X, et al. Hepatitis C in HIV-infected patients with and without AIDS: Prevalence and relationship to patient survival. Hepatology 20.1152-1155, 1994.
95. Areias J, Lopes I. Influence of HIV infection in chronic hepatitis C in intravenous drug addicts. Hepatology 16:195A, 1992.
96. Novick DM, Farci P, Croxson TS, et al. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis 158:795-803, 1988.
97. Buti M, Estaban R, Espanol M, et al. Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis. J Infect Dis 163:1351-1353, 1991
98. Krogsgaard K, Kryger P, Aldershrile J, et al. Delta-infection and suppression of hepatitis B virus replication in chronic HB-sAg carriers. Hepatology 7:42-45, 1987